| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |